Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study.
EQ-5D
General public values
Health state valuation
Time trade-off
Journal
The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
02
10
2021
accepted:
16
08
2022
medline:
26
6
2023
pubmed:
3
9
2022
entrez:
2
9
2022
Statut:
ppublish
Résumé
To determine the effects of age, immigrant background, and poor self-reported health in a general population sample on the probability of non-completion or slow completion of the time trade-off (TTO). We used data from an interrupted Norwegian EQ-5D-5L valuation study conducted between 2019 and 2020. All participants responded to background items, irrespective of completion. We used mixed effect logistic regression analysis to assess the effect of old age, poor health, and immigrant background on the probability of non-completion of the TTO, and, for those who completed the TTO, of slow completion times. First experiences from a Norwegian valuation study were that 29 (5.5%) respondents failed to complete the TTO tasks. For those reporting age over 65 years, poor health, or an immigrant background, 12% failed to complete the TTO. Adjusted odds ratios for predictors of non-completion were statistically significant (age > 65 years, 8.3; EQ-VAS ≤ 50, 3.49; immigrant background, 4.56). Being over 65 years or with an immigrant background also predicted slow completion of both the introduction and TTO tasks. High age, poor health, and immigrant status increased the risk of not being able to complete the TTO tasks, and of slow completion. Higher non-completion rates and increased completion times suggest that elements of the TTO may be demanding for some respondent groups, with possible implications for representativeness.
Identifiants
pubmed: 36053383
doi: 10.1007/s10198-022-01517-y
pii: 10.1007/s10198-022-01517-y
pmc: PMC9438383
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
877-884Subventions
Organisme : Norges Forskningsråd
ID : 262673
Informations de copyright
© 2022. The Author(s).
Références
Rowen, D., Azzabi Zouraq, I., Chevrou-Severac, H., van Hout, B.: International regulations and recommendations for utility data for health technology assessment. PharmacoEconomics. 35(1), 11–19 (2017). https://doi.org/10.1007/s40273-017-0544-y
doi: 10.1007/s40273-017-0544-y
pubmed: 29052162
Wisloff, T., Hagen, G., Hamidi, V., Movik, E., Klemp, M., Olsen, J.A.: Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010. PharmacoEconomics. 32(4), 367–375 (2014). https://doi.org/10.1007/s40273-014-0136-z
doi: 10.1007/s40273-014-0136-z
pubmed: 24477679
pmcid: 3964297
Kim, S.H., Ahn, J., Ock, M., Shin, S., Park, J., Luo, N., Jo, M.W.: The EQ-5D-5L valuation study in Korea. Qual. Life Res. 25(7), 1845–1852 (2016). https://doi.org/10.1007/s11136-015-1205-2
doi: 10.1007/s11136-015-1205-2
pubmed: 26961008
Versteegh, M., Vermeulen, K., Evers, S., de Wit, A., Prenger, R., Stolk, E.: Dutch tariff for the five-level version of EQ-5D. Value Health. 19(4), 343–352 (2016). https://doi.org/10.1016/j.jval.2016.01.003
doi: 10.1016/j.jval.2016.01.003
Xie, F., Pullenayegum, E., Gaebel, K., Bansback, N., Bryan, S., Ohinmaa, A., Poissant, L., Johnson, J.A.: A time trade-off-derived value set of the EQ-5D-5L for Canada. Med. Care. 54(1), 98–105 (2016). https://doi.org/10.1097/mlr.0000000000000447
doi: 10.1097/mlr.0000000000000447
pubmed: 26492214
Luo, N., Liu, G., Li, M., Guan, H., Jin, X., Rand-Hendriksen, K.: Estimating an EQ-5D-5L Value Set for China. Value Health. 20(4), 662–669 (2017). https://doi.org/10.1016/j.jval.2016.11.016
doi: 10.1016/j.jval.2016.11.016
pubmed: 28408009
Lin, H.-W., Li, C.-I., Lin, F.-J., Chang, J.-Y., Gau, C.-S., Luo, N., Pickard, A.S., Ramos Goñi, J.M., Tang, C.-H., Hsu, C.-N.: Valuation of the EQ-5D-5L in Taiwan. PLOS ONE. 13(12), e0209344 (2018). https://doi.org/10.1371/journal.pone.0209344
doi: 10.1371/journal.pone.0209344
pubmed: 30586400
pmcid: 6306233
Pattanaphesaj, J., Thavorncharoensap, M., Ramos-Goñi, J.M., Tongsiri, S., Ingsrisawang, L., Teerawattananon, Y.: The EQ-5D-5L valuation study in Thailand. Expert Rev. Pharmacoecon. Outcomes Res. 18(5), 551–558 (2018). https://doi.org/10.1080/14737167.2018.1494574
doi: 10.1080/14737167.2018.1494574
pubmed: 29958008
Ramos-Goñi, J.M., Craig, B.M., Oppe, M., Ramallo-Fariña, Y., Pinto-Prades, J.L., Luo, N., Rivero-Arias, O.: Handling data quality issues to estimate the Spanish EQ-5D-5L value set using a hybrid interval regression approach. Value Health. 21(5), 596–604 (2018). https://doi.org/10.1016/j.jval.2017.10.023
doi: 10.1016/j.jval.2017.10.023
pubmed: 29753358
Wong, E.L.Y., Ramos-Goñi, J.M., Cheung, A.W.L., Wong, A.Y.K., Rivero-Arias, O.: Assessing the use of a feedback module to model EQ-5D-5L health states values in Hong Kong. Patient. 11(2), 235–247 (2018). https://doi.org/10.1007/s40271-017-0278-0
doi: 10.1007/s40271-017-0278-0
pubmed: 29019161
Ferreira, P.L., Antunes, P., Ferreira, L.N., Pereira, L.N., Ramos-Goñi, J.M.: A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set. Qual. Life Res. 28(12), 3163–3175 (2019). https://doi.org/10.1007/s11136-019-02226-5
doi: 10.1007/s11136-019-02226-5
pubmed: 31201730
Golicki, D., Jakubczyk, M., Graczyk, K., Niewada, M.: Valuation of EQ-5D-5L health states in Poland: the First EQ-VT-based study in central and Eastern Europe. PharmacoEconomics. 37(9), 1165–1176 (2019). https://doi.org/10.1007/s40273-019-00811-7
doi: 10.1007/s40273-019-00811-7
pubmed: 31161586
pmcid: 6830402
Rencz, F., Brodszky, V., Gulácsi, L., Golicki, D., Ruzsa, G., Pickard, A.S., Law, E.H., Péntek, M.: Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary. Value Health. 23(9), 1235–1245 (2020). https://doi.org/10.1016/j.jval.2020.03.019
doi: 10.1016/j.jval.2020.03.019
pubmed: 32940242
Burstrom, K., Sun, S., Gerdtham, U.G., Henriksson, M., Johannesson, M., Levin, L.A., Zethraeus, N.: Swedish experience-based value sets for EQ-5D health states. Qual. Life Res. 23(2), 431–442 (2014). https://doi.org/10.1007/s11136-013-0496-4
doi: 10.1007/s11136-013-0496-4
pubmed: 23975375
Leidl, R., Reitmeir, P.: An experience-based value set for the EQ-5D-5L in Germany. Value Health. 20(8), 1150–1156 (2017). https://doi.org/10.1016/j.jval.2017.04.019
doi: 10.1016/j.jval.2017.04.019
pubmed: 28964448
De Abreu Lourenço, R., Devlin, N., Howard, K., Ong, J.J., Ratcliffe, J., Watson, J., Willing, E., Huynh, E.: Giving a voice to marginalised groups for health care decision making. Patient - Patient-Cent. Outcomes Res. 14(1), 5–10 (2021). https://doi.org/10.1007/s40271-020-00456-1
doi: 10.1007/s40271-020-00456-1
de Freitas, C., Martin, G.: Inclusive public participation in health: Policy, practice and theoretical contributions to promote the involvement of marginalised groups in healthcare. Soc. Sci. Med. 135, 31–39 (2015). https://doi.org/10.1016/j.socscimed.2015.04.019
doi: 10.1016/j.socscimed.2015.04.019
pubmed: 25939074
Snow, M.E., Tweedie, K., Pederson, A.: Heard and valued: the development of a model to meaningfully engage marginalized populations in health services planning. BMC Health Serv. Res. 18(1), 181 (2018). https://doi.org/10.1186/s12913-018-2969-1
doi: 10.1186/s12913-018-2969-1
pubmed: 29544486
pmcid: 5856315
INVOLVE. INVOLVE. Available from: https://www.involve.org.uk/ (2018). Accessed 30 Sept 2021
Willing, E., Paine, S.-J., Wyeth, E., Te Ao, B., Vaithianathan, R., Reid, P.: Indigenous voices on measuring and valuing health states. AlterNative: Int. J. Indig. Peoples. 16(1), 3–9 (2019). https://doi.org/10.1177/1177180119885418
doi: 10.1177/1177180119885418
Cubi-Molla, P., Shah, K., Garside, J., Herdman, M., Devlin, N.: A note on the relationship between age and health-related quality of life assessment. Qual. Life Res. 28(5), 1201–1205 (2019). https://doi.org/10.1007/s11136-018-2071-5
doi: 10.1007/s11136-018-2071-5
pubmed: 30523567
Rowen, D., Mulhern, B., Banerjee, S., Tait, R., Watchurst, C., Smith, S.C., Young, T.A., Knapp, M., Brazier, J.E.: Comparison of general population, patient, and carer utility values for dementia health states. Med. Decis. Mak. 35(1), 68–80 (2014). https://doi.org/10.1177/0272989X14557178
doi: 10.1177/0272989X14557178
Ubel, P.A., Loewenstein, G., Jepson, C.: Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual. Life Res. 12(6), 599–607 (2003). https://doi.org/10.1023/a:1025119931010
doi: 10.1023/a:1025119931010
pubmed: 14516169
Stolk, E., Ludwig, K., Rand, K., van Hout, B., Ramos-Goñi, J.M.: Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health. 22(1), 23–30 (2019). https://doi.org/10.1016/j.jval.2018.05.010
doi: 10.1016/j.jval.2018.05.010
pubmed: 30661630
Oppe, M., Rand-Hendriksen, K., Shah, K., Ramos-Goni, J.M., Luo, N.: EuroQol protocols for time trade-off valuation of health outcomes. PharmacoEconomics. 34(10), 993–1004 (2016). https://doi.org/10.1007/s40273-016-0404-1
doi: 10.1007/s40273-016-0404-1
pubmed: 27084198
pmcid: 5023738
Edelaar-Peeters, Y., Stiggelbout, A.M., Van Den Hout, W.B.: Qualitative and quantitative analysis of interviewer help answering the time tradeoff. Med. Decis. Mak. 34(5), 655–665 (2014). https://doi.org/10.1177/0272989X14524989
doi: 10.1177/0272989X14524989
Lamers, L.M., Stalmeier, P.F.M., Krabbe, P.F.M., Busschbach, J.J.V.: Inconsistencies in TTO and VAS values for EQ-5D health states. Med. Decis. Mak. 26(2), 173–181 (2006). https://doi.org/10.1177/0272989X06286480
doi: 10.1177/0272989X06286480
Shen, J., Hill, S., Mott, D., Breckons, M., Vale, L., Pickard, R.: Conducting a time trade-off study alongside a clinical trial: a case study and recommendations. PharmacoEconomics - Open. 3(1), 5–20 (2019). https://doi.org/10.1007/s41669-018-0084-1
doi: 10.1007/s41669-018-0084-1
pubmed: 29949064
Hansen, T.M., Helland, Y., Augestad, L.A., Rand, K., Stavem, K., Garratt, A.: Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol valuation technology (EQ-VT) protocol. BMJ Open. 10(6), e034683 (2020). https://doi.org/10.1136/bmjopen-2019-034683
doi: 10.1136/bmjopen-2019-034683
pubmed: 32532768
pmcid: 7295408
R_Core_Team. R: A language and environment for statistical computing. R foundation for statistical computing. Available from: https://www.R-project.org/ (2020)
Gudex, C., Dolan, P., Kind, P., Thomas, R., Williams, A.: Valuing health states: interviews with the general public. Eur. J. Public Health. 7(4), 441–448 (1997). https://doi.org/10.1093/eurpub/7.4.441
doi: 10.1093/eurpub/7.4.441
Lugnér, A.K., Krabbe, P.F.M.: An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Rev. Pharmacoecon. Outcomes Res. 20(4), 331–342 (2020). https://doi.org/10.1080/14737167.2020.1779062
doi: 10.1080/14737167.2020.1779062
pubmed: 32552002
Xie, F., Gaebel, K., Perampaladas, K., Doble, B., Pullenayegum, E.: Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med. Decis. Mak. 34(1), 8–20 (2013). https://doi.org/10.1177/0272989X13480852
doi: 10.1177/0272989X13480852
Arnesen, T.T.: M: Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method. J. Health Serv. Res. Policy. 9(1), 43–50 (2004). https://doi.org/10.1258/135581904322716111
doi: 10.1258/135581904322716111
pubmed: 15006240
Boye, K.S., Matza, L.S., Feeny, D.H., Johnston, J.A., Bowman, L., Jordan, J.B.: Challenges to time trade-off utility assessment methods: when should you consider alternative approaches? Expert Rev. Pharmacoecon. Outcomes Res. 14(3), 437–450 (2014). https://doi.org/10.1586/14737167.2014.912562
doi: 10.1586/14737167.2014.912562
pubmed: 24832003
Arnesen, T., Trommald, M.: Are QALYs based on time trade-off comparable? – A systematic review of TTO methodologies. Health Econ. 14(1), 39–53 (2005). https://doi.org/10.1002/hec.895
doi: 10.1002/hec.895
pubmed: 15386674
Xie, F., Pickard, A.S., Krabbe, P.F., Revicki, D., Viney, R., Devlin, N., Feeny, D.: A checklist for reporting valuation studies of multi-attribute utility-based instruments (CREATE). PharmacoEconomics. 33(8), 867–877 (2015). https://doi.org/10.1007/s40273-015-0292-9
doi: 10.1007/s40273-015-0292-9
pubmed: 26026667
pmcid: 4519579
van Nooten, F., Busschbach, J., van Agthoven, M., van Exel, J., Brouwer, W.: What should we know about the person behind a TTO? Eur. J. Health Econ. 19(9), 1207–1211 (2018). https://doi.org/10.1007/s10198-018-0975-1
doi: 10.1007/s10198-018-0975-1
pubmed: 29671142
Health, N.I.o. Inclusion policies for research involving humans subjects. Available from: https://grants.nih.gov/policy/inclusion.htm
Ratcliffe, J., Couzner, L., Flynn, T., Sawyer, M., Stevens, K., Brazier, J., Burgess, L.: Valuing child health utility 9D health states with a young adolescent sample. Appl. Health Econ. Health Policy. 9(1), 15–27 (2011). https://doi.org/10.2165/11536960-000000000-00000
doi: 10.2165/11536960-000000000-00000
pubmed: 21033766
Ratcliffe, J., Hutchinson, C., Milte, R., Nguyen, K.-H., Welch, A., Caporale, T., Corlis, M., Comans, T.: How do people with dementia and family carers value dementia-specific quality of life states? An explorative “think aloud” study. Australas. J. Ageing 38(S2), 75–82 (2019). https://doi.org/10.1111/ajag.12646
doi: 10.1111/ajag.12646
pubmed: 31496068
Ratcliffe, J., Huynh, E., Chen, G., Stevens, K., Swait, J., Brazier, J., Sawyer, M., Roberts, R., Flynn, T.: Valuing the child health utility 9D: using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. Soc. Sci. Med. 157, 48–59 (2016). https://doi.org/10.1016/j.socscimed.2016.03.042
doi: 10.1016/j.socscimed.2016.03.042
pubmed: 27060541
Pickard, A.S., Law, E.H., Jiang, R., Pullenayegum, E., Shaw, J.W., Xie, F., Oppe, M., Boye, K.S., Chapman, R.H., Gong, C.L., Balch, A., Busschbach, J.J.V.: United States valuation of EQ-5D-5L health states using an international protocol. Value Health. 22(8), 931–941 (2019). https://doi.org/10.1016/j.jval.2019.02.009
doi: 10.1016/j.jval.2019.02.009
pubmed: 31426935
Augustovski, F., Rey-Ares, L., Irazola, V., Garay, O.U., Gianneo, O., Fernandez, G., Morales, M., Gibbons, L., Ramos-Goni, J.M.: An EQ-5D-5L value set based on Uruguayan population preferences. Qual. Life Res. 25(2), 323–333 (2016). https://doi.org/10.1007/s11136-015-1086-4
doi: 10.1007/s11136-015-1086-4
pubmed: 26242249
Pullenayegum, E.M., Pickard, A.S., Xie, F.: Latent class models reveal poor agreement between discrete-choice and time tradeoff preferences. Med. Decis. Mak. 39(4), 421–436 (2019). https://doi.org/10.1177/0272989X19841592
doi: 10.1177/0272989X19841592
Augustovski, F., Belizán, M., Gibbons, L., Reyes, N., Stolk, E., Craig, B.M., Tejada, R.A.: Peruvian valuation of the EQ-5D-5L: a direct comparison of time trade-off and discrete choice experiments. Value Health. 23(7), 880–888 (2020). https://doi.org/10.1016/j.jval.2020.05.004
doi: 10.1016/j.jval.2020.05.004
pubmed: 32762989